Wittet Scott, Aylward Jenny, Cowal Sally, Drope Jacqui, Franca Etienne, Goltz Sarah, Kuo Taona, Larson Heidi, Luciani Silvana, Mugisha Emmanuel, Schocken Celina, Torode Julie
PATH, Seattle, WA, USA.
Pink Ribbon Red Ribbon, Washington, DC, USA.
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:57-62. doi: 10.1002/ijgo.12189.
Both human papillomavirus (HPV) vaccination and screening/treatment are relatively simple and inexpensive to implement at all resource levels, and cervical cancer screening has been acknowledged as a "best buy" by the WHO. However, coverage with these interventions is low where they are needed most. Failure to launch or expand cervical cancer prevention programs is by and large due to the absence of dedicated funding, along with a lack of recognition of the urgent need to update policies that can hinder access to services. Clear and sustained communication, robust advocacy, and strategic partnerships are needed to inspire national governments and international bodies to action, including identifying and allocating sustainable program resources. There is significant momentum for expanding coverage of HPV vaccination and screening/preventive treatment in low-resource settings as evidenced by new global partnerships espousing this goal, and the participation of groups that previously had not focused on this critical health issue.
人乳头瘤病毒（HPV）疫苗接种以及筛查/治疗在所有资源水平下实施起来都相对简单且成本低廉，宫颈癌筛查也已被世界卫生组织认定为“性价比高的举措”。然而，在最需要这些干预措施的地方，其覆盖率却很低。未能启动或扩大宫颈癌预防项目，很大程度上是由于缺乏专项资金，以及未认识到迫切需要更新可能阻碍服务获取的政策。需要进行清晰且持续的沟通、有力的宣传以及建立战略伙伴关系，以激励各国政府和国际机构采取行动，包括确定和分配可持续的项目资源。新的全球伙伴关系倡导这一目标，以及此前未关注这一关键健康问题的团体的参与，都表明在资源匮乏地区扩大HPV疫苗接种以及筛查/预防性治疗覆盖率有着巨大的势头。
